Humana Inc (HUM) Dividends

Humana offers a dividend yield of 2.05%, which is generally in line with or slightly above the broader healthcare sector average. The dividend appears sustainable from a traditional earnings perspective, with a payout ratio based on the provided EPS of $9.84 being low, indicating significant coverage. However, a value investor must look deeper at cash generation and balance sheet strength, as outlined in Section 2 of the investment framework. The company's free cash flow yield is only 1.9%, which is below the favourable threshold of a >10-15% FCF margin implied by the framework. This suggests the cash available to fund dividends, buybacks, and growth is relatively thin. While the balance sheet shows a moderate Debt/Equity ratio of 0.72, which is manageable, the underlying profitability metrics are weak. An ROE of 6.7% and an operating margin of 2.1% indicate low returns on capital, which is unfavourable for a quality business. For dividend growth, the 11.3% YoY revenue growth is a positive sign, but dividend increases will ultimately depend on improving the conversion of that top-line growth into stronger, more consistent free cash flow. The low current FCF yield limits aggressive dividend growth potential without leveraging the balance sheet further.